Platelet BioGenesis Augments Board of Directors with Oncology and Immunotherapy Industry Leader Richard Murray, Ph.D.

Platelet BioGenesis, the leader in stem cell-derived, on-demand human platelets (PLTs+™) and platelet-based therapeutics, announced today the addition of Dr. Richard Murray, president and CEO of Jounce Therapeutics, to its board of directors. Read more >>